Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
주식 순위
#4690
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
주가
$3.17
시가총액
$3.21B
변동 (1일)
0.83%
변동 (1년)
-13.30%
국가
CN
거래 Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
카테고리
Healthcare
Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)의 P/S 비율
October 2026 기준 P/S 비율 TTM: 3.51
Jiangsu Nhwa Pharmaceutical Co., Ltd.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 3.51입니다. 2023년 말 기준 P/S 비율은 5.56였습니다.
Jiangsu Nhwa Pharmaceutical Co., Ltd.의 P/S 비율 기록 (2005 ~ 2026)
매년 말 P/S 비율
| 연도 | P/S 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 3.51 | -18.84% |
| 2024 | 4.33 | -22.16% |
| 2023 | 5.56 | -3.45% |
| 2022 | 5.75 | 43.63% |
| 2021 | 4.01 | -16.69% |
| 2020 | 4.81 | 69.51% |
| 2019 | 2.84 | 24.42% |
| 2018 | 2.28 | -44.19% |
| 2017 | 4.09 | -6.45% |
| 2016 | 4.37 | -13.71% |
| 2015 | 5.06 | 29.80% |
| 2014 | 3.90 | -5.58% |
| 2013 | 4.13 | 60.76% |
| 2012 | 2.57 | 28.59% |
| 2011 | 2.00 | -34.40% |
| 2010 | 3.05 | 40.43% |
| 2009 | 2.17 | 71.42% |
| 2008 | 1.27 | -46.07% |
| 2007 | 2.35 | 22.13% |
| 2006 | 1.92 | 13.28% |
| 2005 | 1.70 | 0.00% |
유사 기업 또는 경쟁사의 P/S 비율
| 회사 | P/S 비율 | P/S 비율 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 100.84% |
IN
|
